The post FTX-Linked Caroline Ellison Set for January 2026 Federal Prison Release as SEC Reaches Alameda Research Settlement appeared on BitcoinEthereumNews.com.The post FTX-Linked Caroline Ellison Set for January 2026 Federal Prison Release as SEC Reaches Alameda Research Settlement appeared on BitcoinEthereumNews.com.

FTX-Linked Caroline Ellison Set for January 2026 Federal Prison Release as SEC Reaches Alameda Research Settlement

According to Federal Bureau of Prisons records reported by COINOTAG News on December 26, Caroline Ellison, the former Co-CEO of Alameda Research, is slated for release from federal prison on January 21, 2026. She was moved from a Connecticut facility to home confinement in October, underscoring ongoing adjustments in the high-profile case surrounding Alameda and its leadership.

On December 20, the U.S. Securities and Exchange Commission issued a litigation notice stating that Sam Bankman-Fried, the former head of FTX Trading, remains incarcerated on fraud charges. A settlement has been signed by Ellison and other executives formerly connected to SBF’s operations, including Zixiao Wang and Nishad Singh, though final court approval is still pending.

Source: https://en.coinotag.com/breakingnews/ftx-linked-caroline-ellison-set-for-january-2026-federal-prison-release-as-sec-reaches-alameda-research-settlement

Market Opportunity
Union Logo
Union Price(U)
$0.002878
$0.002878$0.002878
+2.74%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.